Exact Sciences Corp (NAS:EXAS)
$ 54.57 -0.15 (-0.27%) Market Cap: 10.10 Bil Enterprise Value: 11.91 Bil PE Ratio: 0 PB Ratio: 3.15 GF Score: 80/100

Exact Sciences Corp at Credit Suisse Healthcare Conference Transcript

Nov 08, 2022 / 07:35PM GMT
Release Date Price: $40.91 (+7.21%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

With that, the green light signals were live. Thank you all for joining the Exact Sciences presentation. We're lucky to have with us Kevin Conroy, CEO of Exact Sciences; and Jake Orville, the General Manager of the screening operation at Exact Sciences. I'm Dan Leonard. I cover diagnostics for Credit Suisse. Welcome, both of you.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Thanks, Dan, and it's really great to see you again.

Questions & Answers

Daniel Louis Leonard;dit Suisse AG;Kevin T. Conroy<
CrÃ;Research Division - Research Analyst

© -

Likewise, so we have a lot of ground to cover in 30 minutes here. But to start off, Kevin, you just reported Q3 results, I thought we could begin the discussion by circling back to the Q3 performance and highlighting anything you believe worth highlighting from those results to investors.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot